The practice of surgical staging and its impact on adjuvant treatment recommendations in patients with stage I endometrial carcinoma

被引:58
|
作者
Gretz, HF
Economos, K
Husain, A
Lesser, M
Kaplan, E
Caputo, TA
Reynolds, RK
JOhnston, CM
Pearl, ML
Roberts, JA
机构
[1] CORNELL UNIV MED COLL,NEW YORK HOSP,STICH RADIAT ONCOL,NEW YORK,NY 10021
[2] CORNELL UNIV MED COLL,NEW YORK HOSP,DIV BIOSTAT,NEW YORK,NY 10021
[3] UNIV MICHIGAN,MED CTR,ANN ARBOR,MI 48109
[4] SUNY STONY BROOK,STONY BROOK,NY 11790
关键词
D O I
10.1006/gyno.1996.0165
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A survey of American gynecologic oncologists was undertaken to assess their compliance with current surgical staging criteria in patients with early endometrial carcinoma, One hundred forty-four members of the Society of Gynecologic Oncologists responded to the survey, Respondents treated an average of 22 new cases annually. Tumor grade and intraoperative determination of depth of myometrial invasion were demonstrated to influence the frequency of lymphatic dissection. In grade 1, 2, and 3 lesions, 76, 60, and 34% of responders, respectively, indicated that depth of invasion influenced their decision to perform lymphadenectomy, In addition, depth of invasion was important in determining type and extent of lymphatic resection. Further, the impact of pathologic lymph node status on postoperative adjuvant radiation therapy recommendations was evaluated for various stratifications of endometrial adenocarcinoma confined to the corpus, The greatest differences in treatment recommendations were noted in the 50-66% invasion category, For grade 1 and 2 cancers, adjuvant therapy recommendations were reduced by 23 and 16% respectively when comparing pelvic and combined therapy versus none and vaginal therapy. The effect of surgical staging data on clinical decisions is clearly evident. The knowledge of pathologically negative lymph node status reduces the recommendation for postoperative adjuvant radiotherapy in patients with adenocarcinoma otherwise confined to the uterine corpus, (C) 1996 Academic Press, Inc.
引用
收藏
页码:409 / 415
页数:7
相关论文
共 50 条
  • [21] Prognostic factors in surgical stage I endometrial carcinoma
    Lundgren, C
    Auer, G
    Frankendal, B
    Nilsson, B
    Nordström, B
    ACTA ONCOLOGICA, 2004, 43 (01) : 49 - 56
  • [22] The Impact of Adjuvant Management on Survival Endpoints In Women With Stage I Type II Endometrial Carcinoma
    Hermann, Gregory M.
    Ibrahim, Ahmed M.
    Taylor, Andrew
    Tanbour, Hesham E.
    Elshaikh, Mohamed A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 98 (02): : E26 - E27
  • [23] Role of surgical staging and adjuvant treatment in uterine serous carcinoma
    Frey, M. K.
    Bashir, S.
    Ward, N. M.
    Hensel, K. J.
    Caputo, T. A.
    Holcomb, K. M.
    Baergen, R.
    Gupta, D.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2013, 34 (05) : 453 - 456
  • [24] Stage I and II Endometrial Adenocarcinoma: Analysis of 2009 FIGO Staging Revision and Impact on Survival by Adjuvant Therapy
    Cahan, Benjamin
    Kim, Ji Hyun
    Schultheiss, Timothy E.
    Wong, Jeffrey Y. C.
    Chen, Yi-Jen
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2018, 41 (03): : 302 - 306
  • [25] Stage I and II Endometrial Adenocarcinoma: Analysis of 2009 FIGO Staging Revision and Impact on Survival by Adjuvant Therapy
    Kim, J. H.
    Schultheiss, T. E.
    Wong, J. Y.
    Chen, Y.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S96 - S97
  • [26] TREATMENT OF STAGE-I ENDOMETRIAL CARCINOMA
    SCHULZ, MJ
    SHEN, JT
    JOURNAL OF REPRODUCTIVE MEDICINE, 1989, 34 (02) : 167 - 172
  • [27] Impact of surgical staging and adjuvant therapy on recurrence risk and outcome in stage I non-invasive uterine papillary serous carcinoma
    Mahdi, H.
    DeBernardo, R.
    Elshaikh, M.
    Munkarah, A. R.
    Isrow, D.
    Singh, S.
    Waggoner, S. E.
    Ali, R.
    Harding, J.
    Morris, R. T.
    Moslemi-Kebria, M.
    GYNECOLOGIC ONCOLOGY, 2015, 137 : 35 - 35
  • [28] Surgical staging for patients presenting with grade 1 endometrial carcinoma
    Ben-Shachar, I
    Pavelka, J
    Cohn, DE
    Copeland, LJ
    Ramirez, N
    Manolitsas, T
    Fowler, JM
    OBSTETRICS AND GYNECOLOGY, 2005, 105 (03): : 487 - 493
  • [29] Adjuvant high dose rate vaginal brachytherapy as treatment of stage I and II endometrial carcinoma
    Horowitz, NS
    Peters, WA
    Smith, MR
    Drescher, CW
    Atwood, M
    Mate, TP
    OBSTETRICS AND GYNECOLOGY, 2002, 99 (02): : 235 - 240
  • [30] STAGE-I GRADE-III ENDOMETRIAL CARCINOMA - EVALUATION OF TREATMENT AND RECOMMENDATIONS FOR MANAGEMENT
    NUSSBAUM, H
    KAGAN, AR
    CHAN, P
    GILBERT, H
    RAO, A
    HINTZ, B
    SALTZ, A
    GYNECOLOGIC ONCOLOGY, 1981, 11 (01) : 50 - 55